Andrew Hershey
Neurology with Special Qualifications in Child Neurology · Cincinnati, OHNPI 1275567844
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,753 of the $35,511 with a category attached, or 64.1%. 10 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 40.5% of the total.
Across 29 payments — averaging $1224.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$14K
- H. Lundbeck A S$11K
- Pfizer$4K
- Amgen$2K
- Scilex Pharmaceuticals Inc.$2K
- AbbVie$1K
- plus $1K from 4 others
Across 157 payments — averaging $12,649 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$1.2M
- Pfizer$300K
- AbbVie$155K
- H. Lundbeck A S$151K
- Biohaven Pharmaceutical Holding Company Ltd.$92K
- Biohaven Pharmaceuticals, Inc.$52K
- plus $44K from 2 others
What the payments were for
- Consulting fees$22,75364%
- Speaking & faculty fees$11,38332%
- Travel & lodging$5051%
- Food & beverage$8502%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $14,382 |
| H. Lundbeck A S | 4 | $11,383 |
| Pfizer | 3 | $3,805 |
| Amgen | 2 | $2,125 |
| Scilex Pharmaceuticals Inc. | 1 | $1,500 |
| AbbVie(2 entities) | 5 | $1,090 |
| Biogen | 3 | $819 |
| Upsher-smith Laboratories LLC | 2 | $217 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Lundbeck LLC | 1 | $64 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AJOVY$14,202
- VYEPTI$5,250
- AIMOVIG$2,000
- ELYXYB$1,500
- UBRELVY$800
- Zembrace SymTouch Sumatriptan Injection$199
- Tosymra Sumatriptan Nasal Spray$199
- QELBREE$125
- QULIPTA$118
- BOTOX$117
How this compares
$35,511 in reported general payments places this provider in the 85th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
See all neurology with special qualifications in child neurology providers in Ohio →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbamazepine | 15 | $924 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Cincinnati
- Hope O'BrienCincinnati$525K
- Tracy GlauserCincinnati$130K
- Cuixia TianCincinnati$91K
- Shannon StandridgeCincinnati$79K
- Darcy KruegerCincinnati$45K
- Susan FongCincinnati$32K
- Donald GilbertCincinnati$19K
- Marielle SamahaCincinnati$12K
- Gewalin AungaroonCincinnati$8K
- Steven WuCincinnati$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.